Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Multimin 90 is an FDA-approved veterinary injectable trace mineral product for cattle developed by Multimin North America and marketed under Axiota Animal Health. It is a sterile aqueous subcutaneous injection containing zinc, copper, manganese, and selenium, supplied as zinc oxide, copper carbonate, manganese carbonate, and sodium selenite. The product functions as a **multi-mineral replacement and supplementation therapy**, providing essential trace elements that serve as cofactors for numerous enzymes involved in antioxidant defense, immune function, reproduction, and general metabolic health in cattle rather than acting through a single receptor-mediated pharmacology. It is used to provide a supplemental source of these essential trace minerals in cattle and is positioned as a veterinary mineral injectable with restrictions in certain pregnant animals and young calves.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Multimin 90.